Skip to main content
Erschienen in:

10.06.2024 | Case Report

Primary adenocarcinoma arising from rectal implantation cyst after low anterior resection for rectal cancer 31 years previously

verfasst von: Yoshifumi Shimada, Akio Matsumoto, Kaoru Abe, Yosuke Tajima, Mae Nakano, Takashi Ariizumi, Hiroyuki Kawashima, Yusuke Tani, Riuko Ohashi, Toshifumi Wakai

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Rectal implantation cysts can occur at anastomotic sites after low anterior resection (LAR) for rectal cancer. Herein, we report a case of primary adenocarcinoma arising from a rectal implantation cyst after LAR for rectal cancer. A 70-year-old woman was referred to our hospital for diagnosis and treatment of a growing cystic lesion. She had LAR performed for rectal cancer 29 years previously and had a rectal implantation cyst detected 13 years previously. On the first visit to our hospital, serum CEA and CA19-9 levels were elevated, and computed tomography (CT) scans revealed a cystic lesion near the anastomosis. CT-guided biopsy revealed no cancer tissue in the cystic lesion. After that, the cystic lesion naturally shrank, and serum CEA and CA19-9 levels became normal. Follow-up included 3 monthly serum CEA and CA19-9 testing and 6 monthly CT scans. Two years later, serum CEA and CA19-9 levels were elevated again. Colonoscopy revealed an ulcerative lesion at the anastomotic site, in which adenocarcinoma was confirmed. Abdominoperineal resection with sacral resection was performed, and postoperative histopathological examination revealed a primary adenocarcinoma with mucinous component at the implantation cyst. Since rectal implantation cysts can become malignant after extended periods, clinicians need to be aware of this disease.
Literatur
2.
Zurück zum Zitat Honda K, Akahoshi K, Matsui N, et al. Role of EUS and EUS-guided FNA in the diagnosis of rectal implantation cyst at an anastomosis site after a previous low anterior resection for a rectal cancer without evidence of cancer recurrence. Gastrointest Endosc. 2008;68:782–5.CrossRefPubMed Honda K, Akahoshi K, Matsui N, et al. Role of EUS and EUS-guided FNA in the diagnosis of rectal implantation cyst at an anastomosis site after a previous low anterior resection for a rectal cancer without evidence of cancer recurrence. Gastrointest Endosc. 2008;68:782–5.CrossRefPubMed
3.
Zurück zum Zitat Katsumata K, Mori Y, Kawakita H, et al. A study of the incidence of implantation cyst at anastomotic sites after low anterior resection of the rectum with the double stapling technique. Langenbecks Arch Surg. 2010;395:465–9.CrossRefPubMed Katsumata K, Mori Y, Kawakita H, et al. A study of the incidence of implantation cyst at anastomotic sites after low anterior resection of the rectum with the double stapling technique. Langenbecks Arch Surg. 2010;395:465–9.CrossRefPubMed
4.
Zurück zum Zitat Watanabe A, Fukunari H, Mito M, et al. Implantation cyst at anastomosis after anterior resection of the rectum-a report of five cases. Gan To Kagaku Ryoho. 2019;46:2288–90.PubMed Watanabe A, Fukunari H, Mito M, et al. Implantation cyst at anastomosis after anterior resection of the rectum-a report of five cases. Gan To Kagaku Ryoho. 2019;46:2288–90.PubMed
5.
Zurück zum Zitat Fujita Y, Itatani Y, Kawada K, et al. Total pelvic exenteration for mucinous adenocarcinoma arising from an implantation cyst 26 years after surgery for rectal cancer. Asian J Endosc Surg. 2023;16:558–62.CrossRefPubMed Fujita Y, Itatani Y, Kawada K, et al. Total pelvic exenteration for mucinous adenocarcinoma arising from an implantation cyst 26 years after surgery for rectal cancer. Asian J Endosc Surg. 2023;16:558–62.CrossRefPubMed
6.
Zurück zum Zitat Sperti C, Pasquali C, Guolo P, et al. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Cancer. 1996;78:237–43.CrossRefPubMed Sperti C, Pasquali C, Guolo P, et al. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Cancer. 1996;78:237–43.CrossRefPubMed
7.
Zurück zum Zitat Vercellini P, Oldani S, Felicetta II, et al. Serum and cyst fluid tumor marker levels in the differential diagnosis of benign ovarian cysts. J Am Assoc Gynecol Laparosc. 1994;1:S38.CrossRefPubMed Vercellini P, Oldani S, Felicetta II, et al. Serum and cyst fluid tumor marker levels in the differential diagnosis of benign ovarian cysts. J Am Assoc Gynecol Laparosc. 1994;1:S38.CrossRefPubMed
8.
Zurück zum Zitat Murakami T, Akazawa Y, Yatagai N, et al. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study. Diagn Pathol. 2018;13:88.CrossRefPubMedPubMedCentral Murakami T, Akazawa Y, Yatagai N, et al. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study. Diagn Pathol. 2018;13:88.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Walsh MD, Clendenning M, Williamson E, et al. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol. 2013;26:1642–56.CrossRefPubMed Walsh MD, Clendenning M, Williamson E, et al. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol. 2013;26:1642–56.CrossRefPubMed
10.
Zurück zum Zitat Khaidakov M, Lai KK, Roudachevski D, et al. Gastric proteins MUC5AC and TFF1 as potential diagnostic markers of colonic sessile serrated adenomas/polyps. Am J Clin Pathol. 2016;146:530–7.CrossRefPubMedPubMedCentral Khaidakov M, Lai KK, Roudachevski D, et al. Gastric proteins MUC5AC and TFF1 as potential diagnostic markers of colonic sessile serrated adenomas/polyps. Am J Clin Pathol. 2016;146:530–7.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Koga Y, Hirahashi M, Ohishi Y, et al. Clinicopathological features and phenotypic classification of de novo-type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas. Pathol Int. 2019;69:331–40.CrossRefPubMed Koga Y, Hirahashi M, Ohishi Y, et al. Clinicopathological features and phenotypic classification of de novo-type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas. Pathol Int. 2019;69:331–40.CrossRefPubMed
12.
Zurück zum Zitat Yao T, Tsutsumi S, Akaiwa Y, et al. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res. 2001;92:755–61.CrossRefPubMedPubMedCentral Yao T, Tsutsumi S, Akaiwa Y, et al. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res. 2001;92:755–61.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kurosawa T, Murakami T, Yamashiro Y, et al. Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: correlation with colorectal adenocarcinoma with enteroblastic differentiation. Pathol Res Pract. 2022;232: 153840.CrossRefPubMed Kurosawa T, Murakami T, Yamashiro Y, et al. Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: correlation with colorectal adenocarcinoma with enteroblastic differentiation. Pathol Res Pract. 2022;232: 153840.CrossRefPubMed
14.
Zurück zum Zitat Ozeki H, Shimada Y, Nakano M, et al. Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer. Hum Pathol. 2024;145:71–9.CrossRefPubMed Ozeki H, Shimada Y, Nakano M, et al. Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer. Hum Pathol. 2024;145:71–9.CrossRefPubMed
Metadaten
Titel
Primary adenocarcinoma arising from rectal implantation cyst after low anterior resection for rectal cancer 31 years previously
verfasst von
Yoshifumi Shimada
Akio Matsumoto
Kaoru Abe
Yosuke Tajima
Mae Nakano
Takashi Ariizumi
Hiroyuki Kawashima
Yusuke Tani
Riuko Ohashi
Toshifumi Wakai
Publikationsdatum
10.06.2024
Verlag
Springer Nature Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 5/2024
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-024-02002-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.